1. Vine D, Ghosh M, Wang T, Bakal J.  Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome:  a Canadian Population Cohort.  CJC Open.  2023 Dec 15, 1-32.
  2. Sydora B, Wilke M, Ghosh M, Vine D. Challenges in diagnosis and health care in Polycystic Ovary Syndrome in Canada: a patient view to improve health care.  BMC Women’s Health.   2023 Nov 4;23(1):569.
  3. Navarese E, Vine D, Proctor S, Grzelakowska K, Berti S, Kubika J and Raggi P. (2023).  Independent Causal Effect of Remnant Cholesterol on Atherosclerotic Cardiovascular Outcomes: a Mendelian randomization study., 43 (9), e3873-e380.. Arterioscler Thromb Vasc Biol.  doi: 10.1161/ATVBAHA.123.319297.
  4. Donna Vine, Ethan Proctor, Olivia Weaver, Mahua Ghosh, Katerina Maximova, Spencer Proctor.  (2021).  A Pilot Trial: Fish Oil and Metformin Effects on ApoB-Remnants and Triglycerides in Women With Polycystic Ovary Syndrome.  Journal of the Endocrine Society, Volume 5, Issue 9,  bvab114.   doi: 10.1210/jendso/bvab114.
  5. Vine DF, Beilin LJ, Burrows S, Huang R-C, Hickey M, Hart R, Proctor S, Mori TA. (2020).  ApoB48-Lipoprotein Remnants Are Associated with Increased Plasma Triglycerides and Cardiometabolic Risk Factors in Adolescents with and without Polycystic Ovary Syndrome. J Endocrinology Society, 4 (8):1-12. doi: 10.1210/jendso/bvaa061.
  6. Vine DF, Wang Y, Jetha MM , Ball GDC, Proctor SD. (2017). Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents with Polycystic Ovary Syndrome. Journal Clinical Endocrinology and Metabolism. 102(3): 970-982. doi: 10.1210/jc.2016-2854.
  7. Krysa J, Vine D, Beilin L, Burrow S, Huan R-C, Mori T, Proctor S. (2020). ApoB48-Lipoprotein Remnants Are Associated with Increased Cardiometabolic Risk in Adolescents. Atherosclerosis. 10: 1602-1612. doi: 10.1016/j.atherosclerosis.2020.04.021.
  8. Kupreeva M, Diane A*, Lehner R, Watts R, Ghosh M, Proctor S, Vine DF. (2019). Metformin and Flutamide Differentially Modulate Insulin-Glucose, Lipid and Apo-B Lipoprotein Metabolism, and Reproductive-Endocrine Function in a PCOS-prone rodent model. Am J Physiol: Endocrinol and Metab. 316(1): E16-33. doi: 10.1152/ajpendo.00018.2018.
  9. Diané A, Kupreeva M, Proctor SD, Pierce WD, Vine DF. (2015). Cardiometabolic and reproductive benefits of early dietary energy restriction and voluntary exercise in an obese PCOS-prone rodent model. Journal of Endocrinology. 226(3): 193-206. doi: 0.1530/JOE-14-0711
  10. Vine DF, Shi D, Wang F, Proctor D. (2014). Insulin and Testosterone are associated with elevated intestinal secretion of lipids and lipoproteins in a rodent model of the metabolic and polycystic ovary syndrome. Journal of Diabetes and Metabolism. 5: 391-399. doi: 10.4172/2155-6156.1000391.
  11. Wang Y, Pendlebury C, Dodd MM, Maximova K, Vine DF, Jetha MM, Ball GD, Proctor SD. (2013). Elevated remnant lipoproteins may increase subclinical CVD risk in pre-pubertal children with obesity: a case- control study. Pediatric Obesity. 8(5): 376-84. doi: 10.1111/j.2047-6310.2012.00116.x.
  12. Shi D and Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Reproductive Biology. 2012 Jul;98(1):185-93. doi: 10.1016/j.fertnstert.2012.04.006.
  13. Shi D, Dyck M, Uwiera R, Russell J, Proctor S, Vine DF (2009). A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic and Polycystic Ovary Syndrome. Endocrinology.  Vol. 150, No. 9 4425-4436, Sep 2009. doi: 10.1210/en.2008-1612.